CORE
đșđŠÂ
 make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Optimising pharmacotherapy for secondary prevention of nonâinvasively managed acute coronary syndrome
Author
A randomized trial of propranolol in patients with acute myocardial infarction
AIMâHIGH Investigators Boden WE, Probstfield JL, et al
+11Â more
Chew DP
CURRENTâOASIS 7 Investigators Mehta SR, Bassand JP, et al
Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial IIâDAVIT II)
Esposito G
ISISâ4: a randomised factorial trial assessing early oral captopril oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
January CT
National Institute for Health and Clinical Excellence
Schofield JD
Teo KK
Timololâinduced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
Wiysonge CS
Publication venue
'AMPCo'
Publication date
Field of study
No full text
Crossref
Traditional Heart Failure Medications and Sudden Cardiac Death Prevention
Author
A randomized trial of propranolol in patients with acute myocardial infarction. II
Cameron JS
+5Â more
Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
Effects of Enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
European Heart Rhythm A
Jessup M
Rouleau J
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Author
A randomized trial of propranolol in patients with acute myocardial infarction
ACCF/AHA Task Force on Practice Guidelines
+52Â more
Antzelevitch C
Avierinos JF
Baraona F
Berger JT
Chorin E
Chow T
Claro JC
Claro JC
Claro JC
Cobb LA
Coleman GC
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines Institute of Medicine (US)
Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US)
Conte G
Dhar KL
Dhar R
Dintzis RZ
Goldenberg I
Hookana E
Institute of Medicine
Institute of Medicine
Kapel GF
Koyak Z
Kubac G
Kumar S
Lin CY
Link MS
Link MS
Link MS
McNamara DA
Myerburg RJ
Ortiz M
OâMahony C
Priori SG
Rosso R
Ruwald AC
Saeed M
Saeed M
Santharam S
Solbiati M
Syska P
The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
Wilde AA
Winkel E
Wu Q
Yancy CW
Yancy CW
Yancy CW
Zareba W
Zipes DP
Zipes DP
Zipes DP
Publication venue
'Ovid Technologies (Wolters Kluwer Health)'
Publication date
25/09/2018
Field of study
No full text
Crossref
University of Miami: Scholarship Miami
No full text
